Day: April 5, 2023
Parties add several deliverables to initial R&D collaboration contract
Overall potential revenue increased to up to euro 830 thousandROCKVILLE, Md., April 05, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported today that it signed an amendment to its research and development (“R&D”) collaboration agreement with FIND, to expand the collaboration which was originally started in fall of 2022.
The work already completed under the collaboration will be expanded by three work packages increasing total project volume to up to € 830 thousand in revenue potential. The added deliverables will address the following topics:An Antimicrobial Stewardship Module supporting...
AB Novaturas will present Company’s strategy
Written by Customer Service on . Posted in Public Companies.
On 20th of April at 9:00 AM CEO of AB “Novaturas” Mr. Vitalij Rakovski for investors will present Company’s strategy for 2023-2025 (in English).
We’re kindly asking to register for the webinar using the link below:https://nasdaq.zoom.us/webinar/register/WN_fb10pz5jRU23r_vWueZ9oQ
CFOVygantas Reifonas+370 687 21603
NFI subsidiary Alexander Dennis repurposes Larbert facility to increase zero-emission manufacturing capability
Written by Customer Service on . Posted in Public Companies.
NFI’s Alexander Dennis facility at Larbert (1)
NFI subsidiary Alexander Dennis repurposes Larbert facility to increase zero-emission manufacturing capabilityLARBERT, United Kingdom, April 05, 2023 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, subsidiary Alexander Dennis Limited (“Alexander Dennis”) today announced plans to expand its Larbert head office and facility into a manufacturing site for the future.
The Larbert site will focus on the production of the new Enviro400EV zero-emission bus from August 2023, assembling the next-generation body on the new Alexander Dennis battery-electric chassis. The decision follows a successful pilot program to build Enviro400FCEV hydrogen...
Kraig Biocraft Laboratories Preparing Response to U.S. Department of Defense Request for Information on Domestic Biomanufacturing of Spider Silk
Written by Customer Service on . Posted in Public Companies.
ANN ARBOR, Mich., April 05, 2023 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces today that it is preparing a response to the United States Air Force under the Defense Production Act Investments (DPAI) program. In its efforts to strengthen the U.S. bio-industrial manufacturing capabilities, the U.S. Government is seeking input from industry to identify target areas for governmental investment.
Under the 2023 National Defense Authorization Act and through executive order, the Secretary of Defense has been authorized to “incentives the expansion of domestic, flexible industrial biomanufacturing capacity for a wide range of materials.” Biosynthetic...
Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians
Written by Customer Service on . Posted in Public Companies.
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today announced the appointment of Arshad M. Khanani, M.D., M.A, F.A.S.R.S and Lejla Vajzovic, M.D., F.A.S.R.S to its Scientific Advisory Board (SAB).
Clearside’s SAB is comprised of industry leading retinal physicians who provide medical and scientific expertise and input on the Company’s research and development programs. The SAB members are:
Thomas A. Ciulla, M.D., M.B.A., ChairDavid S. Boyer, M.D.David M. Brown, M.D.Arshad M. Khanani, M.D., M.A., F.A.S.R.S.Carl D. Regillo, M.D., F.A.C.S Lejla Vajzovic, M.D., F.A.S.R.S.
“We are honored to have these esteemed clinicians provide valuable feedback as we advance...
With 4.4% CAGR, Airway Management Devices Market Size to Hit USD 2.55 Billion by 2029
Written by Customer Service on . Posted in Mergers And Acquisitions.
According to Fortune Business Insights, The global airway management devices market size was valued at USD 1.81 billion in 2021 and is projected to reach a valuation of USD 1.89 billion in 2022. The market is expected to reach USD 2.55 billion by 2029 with a CAGR of 4.4% during the forecast period.
Pune, India, April 05, 2023 (GLOBE NEWSWIRE) — The global airway management devices market size was valued at USD 1.81 billion in 2021 and is projected to reach a valuation of USD 1.89 billion in 2022. The market is expected to reach USD 2.55 billion by 2029 with a CAGR of 4.4% during the forecast period. Owing to rising cases of chronic diseases such as chronic obstructive pulmonary disease (COPD), cancer, chronic lung diseases, and others have put emphasis on better treatment of such conditions. Rising number of joint ventures and...
Internet of Things Market Size Expected to Surpass USD 3352.97 Billion, exhibiting a 26.1% CAGR by 2030
Written by Customer Service on . Posted in Mergers And Acquisitions.
According to Fortune Business Insights, the global IoT market size is projected to reach USD 3352.97 billion in 2030, at a CAGR of 26.1% during the forecast period, 2023-2030
Pune, India, April 05, 2023 (GLOBE NEWSWIRE) — The global internet of things market size was valued at USD 544.38 billion in 2022. The market is estimated to expand from USD 662.21 billion in 2023 to USD 3,352.97 billion in 2030, exhibiting a CAGR of 26.1% over the projected period. The expansion is due to the availability of a range of solutions such as integrated solutions, vehicle solutions, deployment services, and others. Fortune Business Insights™ provides this information in its research report, titled “Internet of Things Market Forecast, 2023-2030”.Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/internet-of-things-iot-market-100307Key...
Red Pine Announces Resignation of Director
Written by Customer Service on . Posted in Public Companies.
TORONTO, April 05, 2023 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company“) announces that Mr. Nils Engelstad, Alamos Gold Inc.’s (“Alamos”) nominee on the Company’s board of directors (the “Board”), has resigned as a member of the Board, effective April 4, 2023. Alamos will continue to have the right to nominate one member to the Board provided it continues to beneficially own at least 10% of the issued and outstanding common shares of the Company pursuant to the terms of its Investor Rights Agreement with the Company.
About Red Pine Exploration Inc.
Red Pine Exploration Inc. is a gold exploration company headquartered in Toronto, Ontario, Canada. The Company’s shares trade on the TSX Venture Exchange under the symbol “RPX” and on the OTCQB Markets under...
Pharvaris Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Top-line data from CHAPTER-1, a proof-of-concept Phase 2 study of PHVS416 for the prophylactic treatment of HAE, anticipated in 2H2023
26-week non-clinical toxicology study intended to address the clinical holds in the U.S. initiated; submission of study results anticipated by YE2023
Adoption of deucrictibant as the global nonproprietary name for PHA121
Executing from a strong financial position with cash and cash equivalents of €162 million as of December 31, 2022ZUG, Switzerland, April 05, 2023 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today reported financial results for the fourth quarter and year ended December 31, 2022 and provided a business update.
“Our first in-patient data...
Testing, Inspection, and Certification Market Size Predicted to Reach USD 328.23 Billion, exhibiting a 6.1% CAGR by 2029
Written by Customer Service on . Posted in Mergers And Acquisitions.
According to Fortune Business Insights, the global Testing, Inspection, and Certification Market size is projected to reach USD 328.23 Billion by 2029, at a CAGR of 6.1% during the forecast period, 2022-2029
Pune, India, April 05, 2023 (GLOBE NEWSWIRE) — The global testing, inspection, and certification market size was valued at USD 208.43 billion in 2021. The market is projected to grow from USD 217.31 billion in 2022 to USD 328.23 billion by 2029, exhibiting a CAGR of 6.1% during the forecast period. Rising Demand for Testing Services in Manufacturing Industry to Fuel Market Growth. Fortune Business Insights provide this information in its report titled “Global Testing, Inspection, and Certification Market Forecast, 2023-2029.”
Industry Developments-
Socotec Italia purchased Tecnolab Srl, an Italian company that does geotechnical...